Fig. 3: AEA measurements and 95% CI over time in the groups; Allergic reaction on 3rd dose, 4th dose, and 5th dose compared to no inactivation. | Leukemia

Fig. 3: AEA measurements and 95% CI over time in the groups; Allergic reaction on 3rd dose, 4th dose, and 5th dose compared to no inactivation.

From: Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia

Fig. 3

AEA measurements day 1,4,7 and 11 after first dose and AEA Ctrough after every dose of peg-asparaginase for patients <16 years (IV administration). Patients without inactivation are shown in red, those experiencing allergic reactions on the 3rd dose in blue, on the 4th dose in green, and on the 5th dose in black.

Back to article page